GlaxoSmithKline Pharmaceuticals Limited's total assets for Q1 2026 were ₹0.00, a decrease of -100.00% from the previous quarter. IN:GLAXO total liabilities were ₹-19.51B for the fiscal quarter, a -190.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Total Assets
₹ 41.08B
₹ 35.57B
₹ 33.27B
₹ 46.33B
₹ 31.13B
Total Liabilities
₹ 21.57B
₹ 17.79B
₹ 15.85B
₹ 19.70B
₹ 16.14B
Total Equity Gross Minority
₹ 19.51B
₹ 17.78B
₹ 17.41B
₹ 26.63B
₹ 14.99B
Other Metrics
Currency in INR
GlaxoSmithKline Pharmaceuticals Limited Debt to Assets